期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical evidence of growth hormone for patients undergoing abdominal surgery: Meta-analysis of randomized controlled trials 被引量:6
1
作者 YongZhou Xiao-TingWu +2 位作者 gangyang WenZhuang Mao-LingWei 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第25期3925-3930,共6页
AIM: To assess the effectiveness and safety of perioperative growth hormone (GH) in patients undergoing abdominal surgery.METHODS: We searched the following electronic databases: MEDLINE, EMBASE, the Cochrane Controll... AIM: To assess the effectiveness and safety of perioperative growth hormone (GH) in patients undergoing abdominal surgery.METHODS: We searched the following electronic databases: MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Chinese Bio-medicine Database. The search was undertaken in February 2003. No language restrictions were applied. Randomized controlled trials (RCT) comparing GH with placebo in patients undergoing abdominal surgery were extracted and evaluated.Methodological quality was evaluated using the Jadad scale.RESULTS: Eighteen trials involving 646 patients were included. The combined results showed that GH had a positive effect on improving postoperative nitrogen balance (standardized mean difference [SMD] = 3.37, 95%CI [2.46, 4.27], P<0.00001), and decreasing the length of hospital stay (weighted mean difference [WMD] = -2.07,95%CI [-3.03, -1.11], P = 0.00002), and reducing the duration of postoperative fatigue syndrome (SMD = -1.83,95%CI [-2.37, -1.30], P<0.00001), but it could increase blood glucose levels (WMD = 0.91, 95%CI [0.56, 1.25],P<0.00001).CONCLUSION: GH for patients undergoing abdominal surgery is effective and safe, if blood glucose can be controlled well. Further trials are required with a sufficient size to account for clinical heterogeneity and to measure other important outcomes such as infection, morbidity,mortality, fluid retention, immunomodulatory effects, and tumor recurrence. 展开更多
关键词 临床表现 生长激素 腹部手术 数据分析
下载PDF
Effects of n-3 fatty acid,fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats 被引量:4
2
作者 Xiao-TingWu Jie-ShouLi +5 位作者 Xiao-FeiZhao NingLi Yu-KuiMa WenZhuang YongZhou gangyang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第6期1323-1326,共4页
AIM: To evaluate the effects of n-3 fatty acids (n-3FA),fructose-l,6-diphosphate (FDP) and glutamine (GLN) on mucosal cell proliferation and apoptosis of small bowel graft.METHODS: One hundred and ninety-six inbred st... AIM: To evaluate the effects of n-3 fatty acids (n-3FA),fructose-l,6-diphosphate (FDP) and glutamine (GLN) on mucosal cell proliferation and apoptosis of small bowel graft.METHODS: One hundred and ninety-six inbred strain Wistar rats were grouped as donors and recipients, and underwent heterotopic small bowel transplantation (SBT). n-3FA, FDP and GLN were administered via gastric tube as well as venous infusion for 10 days before and after surgery, respectively.The proliferation and apoptosis of mucosal cells were analyzed with flow cytometry and in situ cell death detection kits.RESULTS: Apparent apoptosis and minor proliferation of mucosal cells of small bowel graft after transplantation were observed. A higher mucosal cell proliferative index and lower apoptotic index were found in all small bowel grafts after supplying with n-3FA, FDP and GLN.CONCLUSION: Nutritional support with n-3FA, FDP and GLN promotes mucosal cell proliferation significantly, and prevents mucosal cell from undergoing apoptosis with different degrees. These regulatory effects on the apoptosis alter the structure and absorption function of transplanted small bowel favorably. 展开更多
关键词 N-3脂肪酸 果糖 6-二磷酸 谷氨酸盐 小肠移植 营养支持
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部